ACCERA
Accera is a biotechnology company that engages in the discovery and development of therapeutic drugs for neurodegenerative diseases. It offers Ketasyn, a molecule for Alzheimer's, Parkinson's, and age-associated memory impairment. It was founded in 2001 and is headquartered in Broomfield, Colorado.
ACCERA
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
2001-01-01
Address:
Broomfield, Colorado, United States
Country:
United States
Website Url:
http://www.accerapharma.com
Total Employee:
51+
Status:
Active
Contact:
(303) 999-3700
Total Funding:
196.22 M USD
Technology used in webpage:
SPF Microsoft Exchange Online Amazon Office 365 Mail Google Maps API Amazon Route 53
Similar Organizations
Aura Biosciences
Aura Biosciences is a biotechnology company that focuses on the development of drugs by using tumor targeted pseudovirions.
Idera Pharmaceuticals
Idera Pharmaceuticals is engaged in the discovery and development of novel synthetic DNA and RNA-based drug candidates.
Novavax
Novavax is a clinical-stage biotechnology company focused on the discovery and development of innovative vaccines.
Vigil Neuroscience
Vigil Neuroscience is a biotechnology company that develops novel therapeutics for neurodegenerative diseases.
Current Advisors List
Board_member
Board_member
2015-01-01
Board_member
Current Employees Featured
Charles Stacey President and CEO @ Accera
President and CEO
2015-01-01
Samuel Henderson Vice President, Research & Development @ Accera
Vice President, Research & Development
William T. Poncy VO Commercial Development @ Accera
VO Commercial Development
Founder
Investors List
Wilmar International
Wilmar International investment in Venture Round - Accera
Inventages Venture Capital Investment Inc.
Inventages Venture Capital Investment Inc. investment in Venture Round - Accera
Inventages Venture Capital Investment Inc.
Inventages Venture Capital Investment Inc. investment in Series D - Accera
Bloodstone Ventures
Bloodstone Ventures investment in Series D - Accera
POSCO BioVentures
POSCO BioVentures investment in Series D - Accera
POSCO BioVentures
POSCO BioVentures investment in Series C - Accera
Inventages Venture Capital Investment Inc.
Inventages Venture Capital Investment Inc. investment in Series C - Accera
Inventages Venture Capital Investment Inc.
Inventages Venture Capital Investment Inc. investment in Series B - Accera
POSCO BioVentures
POSCO BioVentures investment in Series A - Accera
Official Site Inspections
http://www.accerapharma.com
- Host name: s3-website-us-east-1.amazonaws.com
- IP address: 54.231.128.213
- Location: Dublin Ireland
- Latitude: 53.3338
- Longitude: -6.2488
- Timezone: Europe/Dublin
- Postal: D02
More informations about "Accera"
Accera - Crunchbase Company Profile & Funding
Organization. Accera . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. ... Contact Email info@accerapharma.com; Phone Number (303) 999-3700; Accera is a …See details»
Accera, Inc. - Broomfield, USA - bionity.com
Nov 10, 2009 accerapharma.com +13039993700. Share. Xing Linkedin Facebook X E-mail Loading... Bookmark. Bookmark list; Bookmark. Accera, Inc. 380 Interlocken Crescent Suite …See details»
Accera - VentureRadar
Accera is a biopharmaceutical company with a breakthrough drug for Alzheimer's in late stage clinical testing. Accera's pipeline consists of novel... ... Find out ...See details»
Specialty biotech in late stage development of an Alzheimer’s …
Www.accerapharma.com. Contact Information – Accera, Inc. Dr. Charles Stacey, MD Ernest Wong, PhD, MBA President & CEO VP, Corporate Development Mobile: (720)-412-3955 …See details»
Accera, Inc. Appoints Dr. Thomas Werner President & CEO and …
Oct 5, 2010 For more information about Accera, please visit www.accerapharma.com. Company contact: Accera, Inc. (303) 999-3705. Bill Poncy. VP Commercial Development [email …See details»
Accera - EquityNet
Chief Executive Officer Holger K..... With more than 30 years managerial experience with multinational pharmaceutical and nutrition companies, Holger K....., currently serves as …See details»
Accera Inc - Company Profile and News - Bloomberg Markets
Company profile page for Accera Inc including stock price, company news, executives, board members, and contact informationSee details»
Accera, Inc. Completes $35 Million Series C Financing
Nov 11, 2008 Accera, Inc. Completes $35 Million Series C Financing BROOMFIELD, Colo., Nov. 11 /PRNewswire/ -- Accera, Inc., a biotechnology company delivering breakthrough therapies …See details»
Accera, Inc. Completes $35 Million Series C Financing
Nov 11, 2008 For more information, visit www.accerapharma.com. Contacts Media: Investors: Kelly McKenna Greg Kading MS&L Worldwide Vice President, Finance (415) 293-2808 …See details»
Accera - Crunchbase Company Profile & Funding
Accera is a biotechnology company that engages in the discovery and development of therapeutic drugs for neurodegenerative diseases.See details»
Nestlé Health Science takes stake in Accera, Inc. to advance …
Jul 20, 2012 Accera, Inc., a privately-held, commercial-stage, healthcare company focused on the discovery and development of innovative clinical applications to address acute and chronic …See details»
Accera, Inc. Launches Neuera Pharmaceuticals | Fierce Biotech
Apr 15, 2009 Accera, Inc. Launches Neuera Pharmaceuticals BROOMFIELD, Colo., April 15 -- Accera, Inc., a biotechnology company delivering breakthrough therapies in central nervous …See details»
Accera Announces Results of its First Phase 3 Study in Mild-to …
BOULDER, Colo., Feb. 28, 2017 /PRNewswire/ -- Accera, Inc., a leading CNS therapeutics company, today announced results of the AC-1204 Phase 3 study for the treatment of mild-to …See details»
Small biotech Accera reinvents itself, takes aim at Alzheimer's ...
Jun 8, 2016 The Alzheimer’s Association has also expressed concern about medical foods as a treatment for the disease, particularly as the lack of FDA approval means the data supporting …See details»
Cerecin Neurosciences
Jun 23, 2015 The war against Alzheimer’s disease has been a brutal, losing fight. Those stricken with the disease, their loved ones, and their doctors are on the front lines every day, but the …See details»
About us | Accès pharma
At Accès pharma, our priorities are availability and providing accessible health care as demonstrated in more of our 68 affiliated pharmacies.See details»
Cerecin Neurosciences
Cerecin forges strategic partnership with A*STAR's Institute of Molecular and Cell Biology (IMCB) in Singapore to advance R&D in neurological disordersSee details»
Accera Raises $35 Million - Fierce Biotech
Nov 12, 2008 Accera Raises $35 Million Accera, Inc., a biotechnology company delivering breakthrough therapies in central nervous system diseases, announced it has recently closed …See details»
Accès pharma | Le réseau de pharmacies affiliées à Walmart au …
Dec 8, 2014 Pour célébrer ses 30 ans, Accès pharma chez Walmart vous envoie où vous voudrez avec le concours Destination santé. À gagner: un chèque-cadeau voyage de 5 000$ …See details»
Vaccination | Accès pharma
Votre pharmacien propriétaire affilié à Accès pharma offre maintenant le service de vaccination contre la grippe. Celui-ci est administré par un pharmacien ou une infirmière.See details»